Foresite Capital Management III’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-6,000	Closed	-$832K	–	22
2016 Q3	$832K	Sell	6,000 -9,000	-60%	-$1.25M	0.39%	16
2016 Q2	$2.72M	Buy	+15,000	New	+$2.72M	1.87%	11